Calcium Hydroxide Patents (Class 424/693)
-
Patent number: 9497981Abstract: The present invention is a process and the product produced by that process for solid, particulate animal feed premixes, characterized by having a certain particle size range, physical stability, hardness range, and rapid dissolution, wherein the premixes contain various drugs and other, pharmaceutically and nutritionally acceptable diluents, binders and formulation aids as needed, or desired.Type: GrantFiled: June 18, 2013Date of Patent: November 22, 2016Assignee: Phibro Animal Health CorporationInventors: Charles Hollett Fahrenholz, Ian John Francis Wilkinson
-
Patent number: 9492464Abstract: A method for preventing or treating side effects of glucocorticoid in a subject including administrating to a subject acetylsalicylic acid a pharmaceutically acceptable salt, solvate, or polymorph thereof, or a combination of at least two of the foregoing.Type: GrantFiled: August 3, 2015Date of Patent: November 15, 2016Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Euiseok Shin, Sangchul Park, Sungchun Cho
-
Patent number: 9060541Abstract: Disclosed is a sterilizer for foods, which contains calcinated calcium or calcium hydroxide and has a higher sterilizing activity than conventional sterilizers. The sterilizer is made up of an aqueous solution or an aqueous dispersion prepared by blending calcinated calcium or calcium hydroxide, ethanol, and sodium lactate.Type: GrantFiled: June 24, 2010Date of Patent: June 23, 2015Assignees: Kawakami Co., Ltd., Kyoto UniversityInventors: Hiroo Kawakami, Mitsuaki Nishibuchi, Noriko Kotani, Yasuharu Yamashita
-
Publication number: 20150147412Abstract: Disclosed is a composition for treating sulfuric acid burn, wherein the composition may be used as a topical medication. The composition generally includes isopropyl alcohol or L-valine solution; at least one active therapeutic substance and/or a disinfectant for treating the burn; calcium hydroxide for neutralizing the acid; a humectant and/or a clinging agent for preventing the acid from spreading; an expectorant for signaling the body to clear any irritations caused by the acid; an acid indicator for visually signaling presence of the acid; and fumed silica as a thickening agent for slowing the reaction time of the acid. In a preferred embodiment, and without limitation, the therapeutic substances may include eugenol and thymol, and the disinfectants may include turmeric powder and hydrogen peroxide. Additionally, glycerin and sugar are used as clinging agents to reduce the chemical reaction between the sulfuric acid and surrounding tissue or materials exposed thereto.Type: ApplicationFiled: November 19, 2014Publication date: May 28, 2015Inventor: Mark Greene
-
Patent number: 8980330Abstract: Provided is a method that enables a calcium silicate-based material to be produced more efficiently. The method of producing a calcium silicate-based material comprises: (1) a step of obtaining a reaction product by reacting raw materials containing a calcium component, a silicon component and an aluminum component in an aqueous medium; and (2) a step of forming calcium silicate by subjecting the reaction product to hydrothermal treatment.Type: GrantFiled: February 27, 2013Date of Patent: March 17, 2015Assignee: Tomita Pharmaceutical Co., Ltd.Inventors: Koh Konishi, Yuta Tsumura, Seiki Shinomiya, Masashi Konishi, Yukinori Konishi
-
Patent number: 8951505Abstract: Disclosed are systems, methods, compositions and kits for mineralizing tissue, particularly dental tissue. The methods, compositions and kits may be used to strengthen and prevent weakening of the tissue. For example, the methods, compositions and kits may be used for treating and filling cavities in teeth caused by tooth decay.Type: GrantFiled: October 8, 2009Date of Patent: February 10, 2015Assignee: Georgia Health Sciences University Rsearch Institute, Inc.Inventors: David Henry Pashley, Franklin Chi-Meng Tay
-
Publication number: 20140271853Abstract: The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties.Type: ApplicationFiled: May 29, 2014Publication date: September 18, 2014Applicant: SANTARUS, INC.Inventors: Warren Hall, Laura Weston, Kay Olmstead, Laura Gallo, Craig Bowe
-
Publication number: 20140234442Abstract: Disclosed is dental root canal filling (intracanal medicament) compositions that are effective against resistant root canal infections caused by Enterococcus faecalis and Vancomycin-resistant Enterococci.Type: ApplicationFiled: September 17, 2012Publication date: August 21, 2014Inventor: Rajdeep S. Pavaskar
-
Publication number: 20140113254Abstract: A composition for endodontic irrigation is provided. The composition includes a chemical depilatory during intra-canal, and chemo-mechanical instrumentation in endodontic. The composition includes calcium hydroxide or potassium hydroxide, sodium hydroxide, and potassium thioglycolate or calcium thioglycolate to form an effective root canal medicament. Further, the composition may incorporate mineral oil, urea, cetearyl alcohol, D&C yellow No. 8, chromium hydroxide, theobroma cocoa seed butter, iron oxides, fragrances, and ceteareth-20 to enhance its functioning. The composition disinfects, lubricates, chelates, irrigants, dissolves, and facilitates removal of the pulpal tissue and debris. Furthermore, the composition reduces and even eliminates bacteria from micro-endodontic systems. Further, the composition of the present invention enhances eradicating pathogens along with chemo-mechanical debridement of the root canal system.Type: ApplicationFiled: July 30, 2013Publication date: April 24, 2014Inventor: Amy Dukoff
-
Patent number: 8517736Abstract: The present invention relates to a method for reducing or eliminating loss of minerals from the enamel and dental hypersensitivity against temperature changes, in particular when caused by the bleaching of teeth with products containing hydrogen peroxide or other oxidizing agents. After the bleaching process the teeth are treated with a calcium hydroxide containing solution, and subsequently the teeth are treated with a fluoride solution.Type: GrantFiled: January 10, 2012Date of Patent: August 27, 2013Assignee: Dr. Gunnar Rolla Consultant ASInventor: Gunnar Rolla
-
Publication number: 20130122057Abstract: Cements containing certain small molecule amino acid phosphate compounds such as phosphoserine and certain multivalent metal compounds such as but not limited to calcium phosphate have been found to have improved properties and form a macromolecular network in the presence of a bioactive glass material that contain silicates, phosphates, and calcium salts which can be involved in the formation of bonding sites.Type: ApplicationFiled: November 9, 2012Publication date: May 16, 2013Inventors: Venkat R. Garigapati, Matthew E. Murphy, Cassandra L. Kimsey
-
Patent number: 8328917Abstract: The present invention relates to an air filtration system and a method for making a photocatalytic oxidation substrate by powder coating a photocatalyst onto a metal substrate.Type: GrantFiled: October 22, 2010Date of Patent: December 11, 2012Assignee: Garfield Industries, Inc.Inventors: Kirk Garfield, John Potter
-
Patent number: 8323699Abstract: In a method of manufacturing a skin care cream containing baked shell powder, highly calcium-containing shells such as dead shells or pearls is baked and crushed to fine powder to obtain baked shell powder. Then, the obtained baked shell powder is added to mix with a raw material for manufacturing cosmetic cream.Type: GrantFiled: January 15, 2010Date of Patent: December 4, 2012Assignee: Kabushiki Kaisha AsadasyokaiInventor: Kazunobu Sanada
-
Patent number: 8273380Abstract: A beverage for minimizing or reducing jet lag symptoms preferably includes vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin D, zinc, calcium, iodine, magnesium, manganese, ginseng, ginkgo biloba, grape seed extract, Echinacea extract and water. A method for minimizing or reducing jet lag symptoms including ingestion of the beverage by a traveler, one hour prior to a flight, and/or during the flight, and/or after a flight.Type: GrantFiled: May 19, 2009Date of Patent: September 25, 2012
-
Patent number: 8273384Abstract: The present invention provides novel methods of making a non-corrosive base solution for use as an alkalinity increasing agent and/or antioxidant. The present invention further provides novel compositions and methods which can be used to provide relief from disorders related to or complicated by acidosis or excessive free radical or other reactive oxygen species production including, but not limited to, gout, Lesch-Nyhan syndrome, hemochromatosis, Alzheimer's, amyotropic lateral sclerosis, arthritis, atherosclerosis, cancer, cataracts, chronic obstructive pulmonary disease, diabetes, cellulitis, coronary artery disease, heart failure, hypertension, inflammatory bowel disease, macular degeneration, multiple sclerosis, Parkinson's, Reynaud's phenomenon, reperfusion injury, pancreatic impairment, skin infections, Hepatitis C, methicillin-resistant Staphylococcus aureus and infection.Type: GrantFiled: July 2, 2008Date of Patent: September 25, 2012Inventor: Stephen Ray Wurzberger
-
Publication number: 20120231143Abstract: The virus-inactivating effect of calcinated calcium and the like is elucidated, and a novel virus-inactivating agent particularly having a norovirus-inactivating effect is provided. The virus-inactivating agent comprises an aqueous solution or dispersion which is prepared by adding at least one component selected from calcium hydroxide, calcium oxide and calcinated calcium to water. In addition to the above-mentioned components, the virus-inactivating agent may additionally comprise ethanol and a salt of an organic acid.Type: ApplicationFiled: November 9, 2010Publication date: September 13, 2012Applicant: Kawakami Co. LtdInventors: Hiroo Kawakami, Hirohide Kotani, Noriko Kotani, Yasuharu Yamashita
-
Publication number: 20120213716Abstract: The present invention relates to a method for reducing or eliminating loss of minerals from the enamel and dental hypersensitivity against temperature changes, in particular when caused by the bleaching of teeth with products containing hydrogen peroxide or other oxidizing agents. After the bleaching process the teeth are treated with a calcium hydroxide containing solution, and subsequently the teeth are treated with a fluoride solution.Type: ApplicationFiled: January 10, 2012Publication date: August 23, 2012Inventor: Gunnar ROLLA
-
Publication number: 20120009280Abstract: A method of producing an animal feed product from a wet biological material, having a physical form selected from solutions, suspensions, emulsions, gums, mousses, sludges, slurries, and particulate materials, includes the step of combining the biological material with a base comprising a metal oxide in an amount which is sufficient to heat the biological material to a temperature of above 50° C. by reaction of water in the biological material with the metal oxide to produce the animal feed product. The product has a physical form which is easier to handle than that of the wet biological material and is selected from particulate materials and, granular materials. The base is preferably calcium oxide.Type: ApplicationFiled: March 12, 2010Publication date: January 12, 2012Applicant: Bio-Energy Ingredients LimitedInventors: Richard Alwyn Houseman, Abraham Christo Venter
-
Publication number: 20110135749Abstract: The present invention relates to low shrinkage multi functionalized silsesquioxane (SSQ) derivatives, to nanocomposite materials comprising these SSQ's and to the use of the nanocomposite material as a polymerizable resin in biologically compatible materials.Type: ApplicationFiled: March 4, 2008Publication date: June 9, 2011Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCHInventors: Alan Sellinger, Mui Siang Soh, U Jin Adrian Yap
-
Publication number: 20110021355Abstract: The invention relates to formulations of hygroscopic solids with a lipophilic coating layer, and a method of production thereof.Type: ApplicationFiled: April 11, 2009Publication date: January 27, 2011Applicant: BAYER TECHNOLOGY SERVICES GMBHInventors: Jesko Zank, Martin Steinbeck, Guido Becker, Udo Van Stiphout
-
Publication number: 20100310679Abstract: The present invention relates to improved compositions for controlling marine pest anemones, to methods of application of same, and to kits for the convenient dispensing of such compositions.Type: ApplicationFiled: December 31, 2008Publication date: December 9, 2010Inventor: Sharon Ram
-
Publication number: 20100285098Abstract: A method for combating unwanted conditions downstream of the mouth with adhering troches. A method to treat or reduce replication of a virus in throat tissues by releasing an anti-viral from an adhering disc. A method to treat sore throat with time release of Glycyrrhiza extract or collagen from an adhering disc. A method to treat sore throat with topically applied cobalamin. An adhering troche that releases antacid, alginate, bismuth subsalicylate, soluble zinc, such as zinc gluconate, bioactive vitamin B12 (methylcobalamin), antibiotic, or anti-viral. A method to combat bacterial effects downstream of the mouth with topically applied xylitol.Type: ApplicationFiled: September 10, 2008Publication date: November 11, 2010Inventor: Jeffrey T. Haley
-
Publication number: 20100239690Abstract: A composition for oral cavity and skin which contains an antibacterial agent and does not have adverse side effects due to steroids, is provided. The composition contains 0.01 to 4.5% by mass of at least one selected from the group consisting of an antibacterial agent, an antiviral agent, an anti-HIV agent, a non-nucleic acid-based reverse transcriptase inhibitor, an anticancer agent for external use and a disinfectant; 0.01 to 4.5% by mass of a non-steroidal anti-inflammatory agent; 0.001 to 4.5% by mass of a steroidal anti-inflammatory agent; and 0.001 to 10% by mass of a highly water-absorbent polymer or a cellulose derivative.Type: ApplicationFiled: September 19, 2008Publication date: September 23, 2010Inventor: Satoshi Noda
-
Publication number: 20100227006Abstract: A composition comprising a powder mixture of potassium citrate and calcium citrate as mixtures of pure chemical salts and methods of making and using the composition are disclosed. The composition is useful for the treatment and prevention of kidney stones and osteoporosis and better delivers potassium and calcium than commonly used potassium and calcium supplements.Type: ApplicationFiled: May 20, 2010Publication date: September 9, 2010Applicants: MISSION PHARMACAL CO., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEMInventors: Charles Y. C. Pak, Khashayar Sakhaee, Neill B. Walsdorf, SR.
-
Publication number: 20100215643Abstract: Devices are provided which are functionalized to include surface regions having anti-infective agents. Methods are provided for functionalizing various material surfaces to include active surface regions for binding anti-infective agents. Methods are provided by which anti-infective moieties or agents are bonded to functionalized surfaces.Type: ApplicationFiled: February 24, 2010Publication date: August 26, 2010Applicant: ORTHOBOND CORP.Inventors: Randell Clevenger, Jeffrey Schwartz
-
Publication number: 20100068305Abstract: A subject matter of the invention is a mixture, which comprises: a) wax esters; b) at least one metal hydroxide; c) optionally radio-opaque filler; the proportion of the components a), b) and c) in the mixture being at least 93% by weight.Type: ApplicationFiled: September 2, 2009Publication date: March 18, 2010Applicant: ERNST MÜHLBAUER GMBH & CO., KGInventors: Rainer Lueck, Swen Neander
-
Patent number: 7605184Abstract: Inhaled anesthetics with otherwise desirable properties but which are too extensively degraded by passage through absorbents containing calcium hydroxide plus sodium hydroxide (such as soda lime) can be used as anesthetics by substituting absorbents containing calcium hydroxide but devoid of sodium hydroxide or containing minimal amounts of sodium hydroxide.Type: GrantFiled: January 22, 2008Date of Patent: October 20, 2009Inventor: Edmond Eger
-
Publication number: 20090155337Abstract: A method for stabilizing an extra cellular matrix layer in the vascular system of the body is disclosed herein. The method can comprise placing a vascular catheter adjacent to the extra cellular matrix layer, delivering a solution containing a bioflavonoid to the extra cellular matrix layer with the vascular catheter, and cross-linking protein in the extra cellular matrix layer. The bioflavonoid can be a catechin, particularly epigallocatechin gallate (EGCG).Type: ApplicationFiled: November 12, 2008Publication date: June 18, 2009Applicant: ENDOLOGIX, INC.Inventors: Stefan G. Schreck, Kemal Schankereli
-
Publication number: 20090047267Abstract: The present invention provides novel methods of making a non-corrosive base solution for use as an alkalinity increasing agent and/or antioxidant. The present invention further provides novel compositions and methods which can be used to provide relief from disorders related to or complicated by acidosis or excessive free radical or other reactive oxygen species production including, but not limited to, gout, Lesch-Nyhan syndrome, hemochromatosis, Alzheimer's, amyotropic lateral sclerosis, arthritis, atherosclerosis, cancer, cataracts, chronic obstructive pulmonary disease, diabetes, cellulitis, coronary artery disease, heart failure, hypertension, inflammatory bowel disease, macular degeneration, multiple sclerosis, Parkinson's, Reynaud's phenomenon, reperfusion injury, pancreatic impairment, skin infections, Hepatitis C, methicillin-resistant Staphylococcus aureus and infection.Type: ApplicationFiled: July 2, 2008Publication date: February 19, 2009Inventor: Stephen Ray Wurzburger
-
Publication number: 20090041818Abstract: An antiviral agent having been experimentally supported which contains a powder obtained by baking (calcining) dolomite and hydrating a part thereof. Thus, it is possible to provide an antiviral agent which is usable in masks, filters, etc. because of acting directly on viral particles, thus eliminating the infectious capacity of the virus and preventing the invasion of the virus into cells; and a mask and a filter with the use of the antiviral agent.Type: ApplicationFiled: August 10, 2004Publication date: February 12, 2009Inventors: Koichi Otsuki, Toshihiro Ito, Toshiyuki Murase, Hiroshi Ito, Kazuo Wakabayashi, Masami Yakura, Hideaki Yamana
-
Patent number: 7368121Abstract: A process for eradicating moss and liverwort which includes applying sodium percarbonate; and irrigating the moss. In some cases the process includes applying lime to control the pH of the moss and thereby constrain development of additional moss and said sodium percarbonate is a solid material.Type: GrantFiled: October 5, 2005Date of Patent: May 6, 2008Inventor: Robert A Larose
-
Patent number: 7255882Abstract: Benzodiazepine withdrawal induced anxiety is treated by administration of an enkephalinase inhibitor, and a gamma-aminobutyric acid (“GABA”) precursor, or an endorphin or enkephalin releaser. These components promote restoration of normal neurotransmitter function and are non-addictive. Use of the enkephalinase inhibitor D-phenylalanine, the GABA precursor glutamine, the serotonin precursor 5-HTP, glycine, and taurine, in combination with coenzymatic functionality of folic acid is preferred for activation of ligand-gated Cl? channel in the central nervous system. Food supplement embodiments provide the human body nutritional supplements to intake certain neurotransmitter precursor substrates, thereby enabling patients of all ages to self-regulate their ability to quell perturbations to equilibrium and simultaneously to adverse effects upon normal physiological and psychological functioning attributable to induced anxiety and panic associated with benzodiazepine withdrawal.Type: GrantFiled: October 29, 2004Date of Patent: August 14, 2007Inventors: Albert Howard Bieser, Terry Leo Neher
-
Patent number: 7179478Abstract: A method of killing Aiptasia and Majana anemones in aquariums comprises filling a dispenser with an anemone killing mixture, comprising purified water, and effective amounts of calcium hydroxide and non-iodized salt, placing a tip of the filled dispenser near a mouth of an anemone and dispensing a small amount of the mixture such that it is consumed by the anemone. An anemone killing mixture comprises effective amounts of calcium hydroxide and non-iodized salt dissolved into and mixed in boiling purified water.Type: GrantFiled: October 13, 2004Date of Patent: February 20, 2007Inventor: Joseph C. Gatto, Jr.
-
Patent number: 7063865Abstract: A composition that will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side effects associated with hangovers (i.e. headaches, dizziness, nausea, dry mouth, etc) when taken as recommended. The composition includes an effective amount of (I)-glycine, (I)-glutathione, thiamine, magnesium, selenium, molybdenum. Other vitamins, mineral compounds, flavoring, coloring, and solubility agents may also be added.Type: GrantFiled: May 10, 2002Date of Patent: June 20, 2006Inventors: Jeremy Park Jones, Peter Kevin Dobler
-
Patent number: 7029703Abstract: A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.Type: GrantFiled: September 9, 2002Date of Patent: April 18, 2006Assignee: Metagenics, Inc.Inventors: Kim C. Krumhar, Holly A. Johnson
-
Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
Patent number: 6943197Abstract: Provided are methods and topical pharmaceutical formulations for the treatment of inflammatory dermatoses. The invention involves the topical administration of a pharmacologically active base in a formulation having a pH of about 7.5 to about 13.0, preferably about 8.0 to 11.5, and most preferably about 8.5 to 10.5. These basic formulations are particularly suited to the treatment of acne vulgaris.Type: GrantFiled: June 21, 2002Date of Patent: September 13, 2005Inventors: Howard I. Maibach, Eric C. Luo, Tsung-Min Hsu -
Patent number: 6908909Abstract: Acidic oral compositions having reduced tooth erosion characteristics, especially acid beverages such as fruit juice drink concentrates, or oral healthcare products such as mouthwashes, are prepared by adding a calcium compound to the acid composition so that the mol ratio of calcium to acid ranges from 0.3 to 0.8, and the pH of the composition, if necessary after adjustment with an alkali, is from 3.5 to 4.5.Type: GrantFiled: December 10, 2003Date of Patent: June 21, 2005Assignee: SmithKline Beecham plcInventor: David Myatt Parker
-
Patent number: 6881424Abstract: A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a strong oxyacid, wherein the resultant acidic composition is less corrosive to a ferrous metal than a solution of a mineral acid having the same acidic pH value as that of the acidic composition, and where in the acid composition is more biocidal than a mixture of the organic acid and a metal salt of the organic acid which mixture has the same acid normality value as that of the acidic composition. The acidic composition can be prepared by mixing at least one regenerating acid, at least one metal base, and at least one organic acid, wherein the amount of the regenerating acid is in excess of the equivalent amount of the metal base.Type: GrantFiled: September 5, 2000Date of Patent: April 19, 2005Assignee: Mionix CorporationInventors: Maurice Clarence Kemp, Robert Blaine Lalum, David E. Lewis, Robert H. Carpenter
-
Patent number: 6863829Abstract: For providing an anti-bacteria which is made from a natural material, therefore harmless if it is absorbed in the human body, can be produced in mass production with low cost, and shows a high anti-bacteria effect, the anti-bacteria agent is obtained by heating a shell in an atmosphere of inactive gas and burning the shell under the temperature which finally reaches 700° C.-2,500° C.Type: GrantFiled: August 12, 2002Date of Patent: March 8, 2005Assignee: Surfcera Co., Ltd.Inventors: Keiko Sasaki, Manabu Sasaki, Yukio Funai, Kasumi Koyama
-
Patent number: 6846837Abstract: Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a pharmaceutically acceptable base in a formulation having a pH of 7.5 to about 13.0, preferably about 8.0 to 11.5, and most preferably about 8.5 to 10.5. These basic formulations permeate the nail and are effective in treating fungal infections of the nail and surrounding tissues.Type: GrantFiled: June 21, 2002Date of Patent: January 25, 2005Inventors: Howard I. Maibach, Eric C. Luo, Tsung-Min Hsu
-
Patent number: 6841172Abstract: The invention relates to methods and compositions for delivering iron to an iron-deficient patient, more particularly, to methods whereby an iron complex comprising divalent or trivalent ionic iron complexed with one or more low molecular weight anions is administered to a patient by transfer from dialysate. A complex selected according to the invention is non-polymeric; soluble in an aqueous medium; chemically stable, thereby preventing the dissociation of iron ions from the anions under conditions according to the invention; and can be well absorbed into blood and the living body. Also provided are dialysate compositions including therein an iron complex selected according to the invention, and dialysate concentrates which may be diluted to yield an inventive dialysate composition.Type: GrantFiled: August 28, 1998Date of Patent: January 11, 2005Assignee: HemoCleanse, Inc.Inventor: Stephen R. Ash
-
Publication number: 20040247642Abstract: Treatment with magnesium produces a inhibition of acute stent thrombosis under high-shear flow conditions without any hemostatic or significant hemodynamic complications.Type: ApplicationFiled: December 24, 2003Publication date: December 9, 2004Applicant: Cedars-Sinai Medical CenterInventors: Sanjay Kaul, Prediman K. Shah
-
Patent number: 6827766Abstract: Improved area decontamination products and methods of use thereof are provided which include reactive nanoparticles (e.g., metal oxides, hydroxides and mixtures thereof) with one or more biocides and a liquid carrier for the nanoparticles and biocide(s). The products may be formulated for area decontamination as sprays, fogs, aerosols, pastes, gels, wipes or foams, and the presence of reactive nanoparticles enhances the neutralization of undesirable chemical or biological compounds or agents. The nanoparticles may be from the group consisting of the alkali metal, alkaline earth metal, transition metal, actinide and lanthanide oxides and hydroxides and mixtures thereof. In preferred forms, nanocrystalline oxides and hydroxides of Al, Ca, Ce, Mg, Sr, Sn, Ti and Zn are employed having single crystallite sizes of up to about 20 nm and surface areas of at least about 15 m2/g.Type: GrantFiled: October 8, 2002Date of Patent: December 7, 2004Assignee: United States Air ForceInventors: Corrie L. Carnes, Kenneth J. Klabunde, Olga Koper, Lisa S. Martin, Kyle Knappenberger, Paul S. Malchesky, Bill R. Sanford
-
Patent number: 6719963Abstract: Acidic oral compositions having reduced tooth erosion characteristics, especially acid beverages such as fruit juice drink concentrates, or oral healthcare products such as mouthwashes, are prepared by adding a calcium compound to the acid composition so that the mol ratio of calcium to acid ranges from 0.3 to 0.8, and the pH of the composition, if necessary after adjustment with an alkali, is from 3.5 to 4.5.Type: GrantFiled: October 16, 2001Date of Patent: April 13, 2004Assignee: SmithKline Beecham p.l.c.Inventor: David Myatt Parker
-
Patent number: 6692775Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: June 24, 2002Date of Patent: February 17, 2004Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6689392Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.Type: GrantFiled: January 29, 2002Date of Patent: February 10, 2004Assignee: Agricare Ltd.Inventor: Ran Lifshitz
-
Patent number: 6685969Abstract: Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by applying a composition that releases heat when contacted with water. The elevated or decreased temperature immobilizes the parasites and facilitates their mechanical removal, such as by combing.Type: GrantFiled: June 11, 2001Date of Patent: February 3, 2004Assignee: Schering-Plough HealthCare Products, Inc.Inventors: Kurt G. Van Scoik, Marcia S. Schlesinger
-
Patent number: 6627229Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.Type: GrantFiled: June 23, 2001Date of Patent: September 30, 2003Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
-
Patent number: 6572843Abstract: A method for treating hair, combining permanent dyeing and straightening of hair, without significantly damaging the hair. According to the method of the present invention the hair is treated by chemically reducing covalent disulfide linkages in the hair, and contacting said hair with at least one oxidoreductase, at least one mediator, and at least one chemical oxidizing agent in an amount equivalent to 0.001-1% hydrogen peroxide calculated by weight of the dyeing formulation.Type: GrantFiled: March 10, 2000Date of Patent: June 3, 2003Assignee: Novozymes, A/SInventors: Niels Henrik Sorensen, Jason Patrick McDevitt
-
Patent number: 6565891Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.Type: GrantFiled: August 23, 2002Date of Patent: May 20, 2003Assignee: Tsar Health Private Ltd.Inventor: Ranjit Kumar Chandra